logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9248179 B1

PDFFull Text
Expired
Date of Patent:
Feb. 02, 2016

Filed:

Jun. 23, 2011

Pan-lyssavirus vaccines against rabies

Applicants:

Xianfu Wu, Atlanta, GA (US);

Charles E. Rupprecht, Lawrenceville, GA (US);

Ivan V. Kuzmin, Lilburn, GA (US);

Inventors:

Xianfu Wu, Atlanta, GA (US);

Charles E. Rupprecht, Lawrenceville, GA (US);

Ivan V. Kuzmin, Lilburn, GA (US);

Assignee:

The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention, Washington, DC (US);

Attorney:

Klarquist Sparkman, LLP

Primary Examiner:

Michelle S Horning

Int. Cl.
CPC ...
A61K 39/205 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/205 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/70 (2013.01); C12N 2760/20122 (2013.01); C12N 2760/20134 (2013.01); C12N 2760/20143 (2013.01); C12N 2760/20152 (2013.01); C12N 2800/50 (2013.01);
Abstract

Described herein are recombinant rabies viruses encoding rabies virus glycoprotein and at least one heterologous glycoprotein from another, such as Mokola virus, Lagos bat virus and/or West Caucasian bat virus. In particular embodiments, the recombinant rabies virus includes two or three heterologousglycoproteins. The disclosed recombinant rabies viruses can be used as pan-vaccines to provide protection againstthat cause rabies.

Find Patent Forward Citations

Wu, Xianfu. (2016). Pan-lyssavirus vaccines against rabies (U.S. Patent No. 9248179). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9248179

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…